American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$769M |
| 2 |
Kenvue
KVUE
|
+$204M |
| 3 |
Entegris
ENTG
|
+$176M |
| 4 |
Merck
MRK
|
+$148M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$143M |
Top Sells
| 1 |
Nike
NKE
|
+$278M |
| 2 |
Visa
V
|
+$272M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$228M |
| 4 |
Allstate
ALL
|
+$188M |
| 5 |
Wingstop
WING
|
+$165M |
Sector Composition
| 1 | Technology | 25.16% |
| 2 | Financials | 13.26% |
| 3 | Healthcare | 12.3% |
| 4 | Consumer Discretionary | 12.01% |
| 5 | Industrials | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Casella Waste Systems
CWST
$5.79B
| $1.05M | ﹤0.01% |
10,604
-3
| -0% | -$297 |
|
2127
Tetra Tech
TTEK
$9.5B
| $1.04M | ﹤0.01% |
28,280
+7,135
| +34% | +$264K |
|
2128
Q2 Holdings
QTWO
$5.13B
| $1.04M | ﹤0.01% |
19,869
-1,986
| -9% | -$104K |
|
2129
Arcosa
ACA
$4.67B
| $1.04M | ﹤0.01% |
12,110
| – | – |
|
2130
Prestige Consumer Healthcare
PBH
$3.11B
| $1.04M | ﹤0.01% |
14,307
+745
| +5% | +$54.1K |
|
2131
BGC Group
BGC
$4.82B
| $1.04M | ﹤0.01% |
133,575
-10,671
| -7% | -$82.9K |
|
2132
Caledonia Mining Corp
CMCL
$639M
| $1.04M | ﹤0.01% |
93,614
+22,947
| +32% | +$254K |
|
2133
Vanda Pharmaceuticals
VNDA
$266M
| $1.03M | ﹤0.01% |
251,238
+18,743
| +8% | +$77K |
|
2134
CareDx
CDNA
$720M
| $1.03M | ﹤0.01% |
97,198
+34,490
| +55% | +$365K |
|
2135
Park Aerospace
PKE
$372M
| $1.03M | ﹤0.01% |
61,849
-3,583
| -5% | -$59.6K |
|
2136
DraftKings
DKNG
$21.8B
| $1.03M | ﹤0.01% |
22,621
+42
| +0.2% | +$1.91K |
|
2137
Ducommun
DCO
$1.39B
| $1.02M | ﹤0.01% |
19,941
+5,915
| +42% | +$303K |
|
2138
Qiagen
QGEN
$9.82B
| $1.02M | ﹤0.01% |
23,114
+5,152
| +29% | +$228K |
|
2139
InMode
INMD
$937M
| $1.02M | ﹤0.01% |
47,229
-927,583
| -95% | -$20M |
|
2140
Janux Therapeutics
JANX
$1.45B
| $1.02M | ﹤0.01% |
27,055
+15,612
| +136% | +$588K |
|
2141
Clarus
CLAR
$147M
| $1.02M | ﹤0.01% |
150,751
+66,654
| +79% | +$450K |
|
2142
Guaranty Bancshares
GNTY
$557M
| $1.02M | ﹤0.01% |
33,468
-100
| -0.3% | -$3.04K |
|
2143
Lincoln Educational Services
LINC
$622M
| $1.01M | ﹤0.01% |
98,050
+10,507
| +12% | +$109K |
|
2144
SSR Mining
SSRM
$4.54B
| $1.01M | ﹤0.01% |
227,072
-108,593
| -32% | -$484K |
|
|
VERV
2145
DELISTED
Verve Therapeutics
VERV
| $1.01M | ﹤0.01% |
75,975
+29,848
| +65% | +$396K |
|
2146
Calix
CALX
$4.01B
| $1.01M | ﹤0.01% |
30,388
+13,206
| +77% | +$438K |
|
2147
Oric Pharmaceuticals
ORIC
$1.05B
| $1.01M | ﹤0.01% |
73,167
+23,617
| +48% | +$325K |
|
2148
Clarivate
CLVT
$2.88B
| $1M | ﹤0.01% |
135,091
+24,721
| +22% | +$184K |
|
2149
Myriad Genetics
MYGN
$674M
| $1M | ﹤0.01% |
46,937
-104
| -0.2% | -$2.22K |
|
2150
TechTarget
TTGT
$427M
| $1,000K | ﹤0.01% |
30,224
+9,964
| +49% | +$330K |
|